Matt Frevel
Operationeel Directeur bij Migco Pharmaceuticals Ltd.
Profiel
Matt Frevel is currently the Chief Operating Officer at Migco Pharmaceuticals Ltd.
and the Chief Scientific Officer at Enzo Nutraceuticals Ltd.
He holds a doctorate degree from the University of Otago and an undergraduate degree from the University of Bonn.
Actieve functies van Matt Frevel
| Bedrijven | Functie | Begin |
|---|---|---|
Migco Pharmaceuticals Ltd.
 Migco Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Migco Pharmaceuticals Ltd. develops new drug therapeutic products. The firm is focused on developing new drug therapies for the prevention and treatment of migraine headaches. It has clinical safety data for its lead compound MGX-008. The company was founded by Larry Ellsworth Stenswick in 2004 and is headquartered in Rangiora, New Zealand. | Operationeel Directeur | - |
| Enzo Nutraceuticals Ltd. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Matt Frevel
| University of Bonn | Undergraduate Degree |
| University of Otago | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Migco Pharmaceuticals Ltd.
Migco Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Migco Pharmaceuticals Ltd. develops new drug therapeutic products. The firm is focused on developing new drug therapies for the prevention and treatment of migraine headaches. It has clinical safety data for its lead compound MGX-008. The company was founded by Larry Ellsworth Stenswick in 2004 and is headquartered in Rangiora, New Zealand. | Health Technology |
| Enzo Nutraceuticals Ltd. |
